Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-25-019209
Filing Date
2025-02-12
Accepted
2025-02-12 20:15:46
Documents
2
Period of Report
2024-10-23

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 2985
2 EX-24 ffntf-ex24.htm EX-24 19423
  Complete submission text file 0000950170-25-019209.txt   23825
Mailing Address 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054
Business Address 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054 (602) 633-3067
4Front Ventures Corp. (Issuer) CIK: 0001783875 (see all company filings)

EIN.: 834168417 | Fiscal Year End: 1231
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)

Mailing Address C/O 4FRONT VENTURES 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054
Business Address
Kronberg Michael (Reporting) CIK: 0002055505 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-56075 | Film No.: 25616780